Shunt for Hydrocephalus Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Role of Endoscopic Third Ventriculostomy in Management of Malfunctioning Ventriculoperitoneal Shunt
Conditions: Hydrocephalus; Shunt Malfunction Interventions: Device: Endoscopic third ventriculostomy Sponsors: Sohag University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials

The Effect of Education Given to Parents of Children With Ventriculoperitoneal Shunt on Their Anxiety and Self-efficacy
Conditions: Hydrocephalus in Children Interventions: Other: online education Sponsors: Pamukkale University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 15, 2024 Category: Research Source Type: clinical trials

Longitudinal Measurements of Flow in Cerebrospinal Fluid Shunts With a Wireless Thermal Anisotropy Measurement Device
Conditions: Hydrocephalus Interventions: Device: Thermal Anisotropy Measurement Device Sponsors: Rhaeos, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 17, 2023 Category: Research Source Type: clinical trials

Role of Brain Specific Biomarkers in Hydrocephalus
Conditions: Hydrocephalus, Normal Pressure; Biochemical Lesions Head Region; Brain Damage Interventions: Diagnostic Test: Lumbar puncture; Diagnostic Test: External lumbar drainage; Procedure: Ventriculo-peritoneal shunt placement; Procedure: Prechamber puncture; Procedure: Blood sampling #1; Procedure: Blood sampling #2; Procedure: Blood sampling #3; Procedure: Blood sampling #4 and #5 Sponsors: University Hospital Hradec Kralove Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 13, 2023 Category: Research Source Type: clinical trials

CSF Protein Markers as Prognostic Indicators of the Response to CSF Shunt in Normotensive Hydrocephalus
Conditions: Cerebrospinal Fluid Levels of Amyloid Beta 1-42, H-tau and Phospho-tau Proteins; Cognitive Impairment and Its Evolution After Hydrocephalus Treatment; Motor Impairment and Its Evolution After Hydrocephalus Treatment; Ventricular Size and Its Evolution After Implantation of a Ventriculop eritoneal Shunt Intervention: Diagnostic Test: Lumbar CSF protein marker determination Sponsor: University of Valencia Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 22, 2023 Category: Research Source Type: clinical trials